DOI:

10.37988/1811-153X_2025_1_25

Studying the clinical effectiveness of local application of a topical immunomodulator in the treatment of recurrent aphthous stomatitis

Authors

  • O.F. Rabinovich 1, Doctor of Science in Medicine, head of the Oral mucosa diseases Division
    ORCID: 0000-0002-1018-9017
  • I.M. Rabinovich 1, 2, Doctor of Science in Medicine, full professor of the Caries research and endodontics Division
    ORCID: 0000-0001-8539-814X
  • K.V. Umarova 1, PhD in Medical Sciences, researcher of the Oral mucosa diseases Group
    ORCID: 0000-0003-3985-8058
  • T.N. Novozemceva 2, Doctor of Science in Medicine, full professor of the Therapeutic dentistry Department
    ORCID: 0009-0005-1107-0105
  • 1 Central Research Institute of Dental and Maxillofacial Surgery, 119021, Moscow, Russia
  • 2 Russian Medical Academy of Continuous Professional Education, 125993, Moscow, Russia

Abstract

The purpose of the study is to evaluate the effectiveness of local use of the topical immunomodulator «Superlymph» in the treatment of recurrent aphthous stomatitis.
Materials and methods.
A study was conducted on 70 patients aged 18 to 55 years with recurrent aphthous stomatitis. The patients were divided into 2 groups depending on the methods of local treatment. The main group included 40 patients who used the topical immunomodulator «Superlimf» as a local treatment. The control group was represented by 30 patients who used epithelializing agents and medicines affecting the microbiota (antibacterial agents, bacteriophages, local probiotics) for local treatment. The microbial and viral composition of oral scrapings was studied before and after treatment. The dynamics of changes in clinical manifestations were recorded by assessing the degree of pain, the timing of aphthae reduction in size and the timing of their healing.
Results.
Dysbiosis of varying degrees was detected in 80% of patients. Increased growth rates of Streptococcus spp., Staphylococcus spp., Enterobacteriaceae spp., Candida albicans, Neisseria spp. were noted. Herpes viruses were also detected with high frequency. For example, herpes simplex virus type 1 and type 2 were detected in 75% of cases in the main group before treatment, and in 70% of cases in the control group. After local treatment, the results of the study improved in both groups. In the main group, the number of patients with changes in the composition of the microbiota decreased to 30%, and in the control group to 40%. Patients in whom herpes simplex virus type 1 and type 2 was determined after treatment accounted for only 28% in the main group and 40% in the control group. The dynamics of the disease course was also positive in both groups. The average healing time for aphthae in the main group decreased to 7 days, and in the control group to 10 days.
Conclusion.
Local use of the topical immunomodulator» Superlymph» in the treatment of patients with recurrent aphthous stomatitis showed better results along with traditional drugs for local symptomatic treatment.
Conclusion.
Local use of the topical immunomodulator Superlymph in the treatment of patients with recurrent aphthous stomatitis showed better results along with traditional drugs for local symptomatic treatment.

Key words:

recurrent aphthous stomatitis, microbiota, oral mucosa, topical immunomodulator

For Citation

[1]
Rabinovich O.F., Rabinovich I.M., Umarova K.V., Novozemceva T.N. Studying the clinical effectiveness of local application of a topical immunomodulator in the treatment of recurrent aphthous stomatitis. Clinical Dentistry (Russia).  2025; 28 (1): 25—30. DOI: 10.37988/1811-153X_2025_1_25

References

  1. Kaur R., Behl A.B., Punia R.S., Nirav K., Singh K.B., Kaur S. Assessment of prevalence of recurrent aphthous stomatitis in the North Indian population: A cross-sectional study. J Pharm Bioallied Sci. 2021; 13 (Suppl 1): S363-S366. PMID: 34447110
  2. Collado Pérez V.C., Pérez Suárez M.C., Collado Hernández C.M., Pérez Núñez V. [Prevalence of recurrent aphthous stomatitis in a family medical office, Manzanillo, Cuban. A cross-sectional study]. Rev Cient Odontol (Lima). 2023; 11 (4): e172 (In Spanish). PMID: 38312464
  3. Taheri M.H., Eshraqi A.M., Anwari A., Stanikzai A.M. Prevalence of recurrent aphthous ulcers among dentistry students’ in Kabul, Afghanistan: A questionnaire-based study. Clin Cosmet Investig Dent. 2022; 14: 275—279. PMID: 36132195
  4. Baş Y., Seçkin H.Y., Kalkan G., Takcı Z., Önder Y., Çıtıl R., Demir S., Şahin Ş. Investigation of Behçet’s disease and recurrent aphthous stomatitis frequency: The highest prevalence in Turkey. Balkan Med J. 2016; 33 (4): 390—5. PMID: 27606133
  5. Shulman J.D. Prevalence of oral mucosal lesions in children and youths in the USA. Int J Paediatr Dent. 2005; 15 (2): 89—97. PMID: 15790365
  6. Jin B., Wang P., Liu P., Wang Y., Guo Y., Wang C., Jia Y., Zou R., Niu L. Genetic connectivity of gut microbiota and oral ulcers: A Mendelian randomization study. Int Dent J. 2024; 74 (4): 696—704. PMID: 38458846
  7. Yang Z., Cui Q., An R., Wang J., Song X., Shen Y., Wang M., Xu H. Comparison of microbiomes in ulcerative and normal mucosa of recurrent aphthous stomatitis (RAS)-affected patients. BMC Oral Health. 2020; 20 (1): 128. PMID: 32349736
  8. Seoudi N., Bergmeier L.A., Drobniewski F., Paster B., Fortune F. The oral mucosal and salivary microbial community of Behçet’s syndrome and recurrent aphthous stomatitis. J Oral Microbiol. 2015; 7: 27150. PMID: 26037240
  9. Zhu Z., He Z., Xie G., Fan Y., Shao T. Altered oral microbiota composition associated with recurrent aphthous stomatitis in young females. Medicine (Baltimore). 2021; 100 (10): e24742. PMID: 33725829
  10. Grudyanov A.I., Fomenko E.V., Lepikhova A.A., Frolova O.A. Study of the clinical efficacy of the crystalline form of the immunomodulatory drug based on antimicrobial peptides and cytokines complex in the treatment of patients with inflammatory periodontal diseases. International Dental Review. 2022; 4 (101): 12—17 (In Russian). eLIBRARY ID: 49973903
  11. Grudyanov A.I., Fomenko E.V., Berkutova I.S. Clinical evaluation of Superlymph a local immunomodulator in the treatment of patients with a slight chronic generalized periodontitis. Clinical Dentistry (Russia). 2022; 1: 44—47 (In Russian). eLIBRARY ID: 48156197
  12. Proskokova S.V., Voronetskaya V.A., Enikeev A.M., Kutuzov D.N., Pirogov A.E., Bogdanova K.M. Evaluation of the effectiveness of immunomodulatory therapy in the treatment of traumatic lesions of the oral mucosa in orthodontic patients. Medical alphabet. 2023; 20: 35—37 (In Russian). eLIBRARY ID: 55862429

Received

November 25, 2024

Accepted

February 1, 2025

Published on

April 7, 2025